Zhang, K., Wang, J., Tong, T. R., Wu, X., Nelson, R., Yuan, Y., . . . Raz, D. J. (2017). Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma. Int J Cancer.
Citación estilo ChicagoZhang, Keqiang, et al. "Loss of H2B Monoubiquitination Is Associated With Poor-differentiation and Enhanced Malignancy of Lung Adenocarcinoma." Int J Cancer 2017.
Cita MLAZhang, Keqiang, et al. "Loss of H2B Monoubiquitination Is Associated With Poor-differentiation and Enhanced Malignancy of Lung Adenocarcinoma." Int J Cancer 2017.
Precaución: Estas citas no son 100% exactas.